Oxford Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Oxford Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-41,380	Closed	-$4.51M	–	1828
2019 Q2	$4.51M	Buy	41,380 +22,850	+123%	+$2.43M	0.1%	272
2019 Q1	$2.07M	Buy	18,530 +12,846	+226%	+$1.41M	0.05%	564
2018 Q4	$548K	Sell	5,684 -535	-9%	-$56.8K	0.01%	1159
2018 Q3	$758K	Buy	6,219 +3,286	+112%	+$387K	0.02%	1140
2018 Q2	$317K	Buy	+2,933	New	+$314K	0.01%	1483
2018 Q1	–	Sell	-35,545	Closed	-$3.83M	–	1737
2017 Q4	$3.83M	Buy	+35,545	New	+$3.8M	0.08%	300

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Oxford Asset Management's IBB Position: Q3 2019 in Review

Oxford Asset Management sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 41,380 shares — an estimated $4.51M sold.

Oxford Asset Management first reported a position in IBB in Q4 2017 and held it in 6 quarters. The position peaked at $4.51M in Q2 2019. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

Oxford Asset Management reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
Oxford Asset Management sold 41,380 iShares Biotechnology ETF shares in Q3 2019, an estimated $4.51M.
Oxford Asset Management first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 6 quarters.
Oxford Asset Management's iShares Biotechnology ETF position peaked at $4.51M in Q2 2019.
597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Oxford Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.